Clear Labs
   HOME

TheInfoList



OR:

Clear Labs, Inc. is a private
genomics Genomics is an interdisciplinary field of molecular biology focusing on the structure, function, evolution, mapping, and editing of genomes. A genome is an organism's complete set of DNA, including all of its genes as well as its hierarchical, ...
testing company headquartered in
San Carlos, California San Carlos (Spanish language, Spanish for "St. Charles") is a city in San Mateo County, California, United States. The population is 30,722 per the 2020 United States census, 2020 census. History Native Americans Prior to the Spain, Spanis ...
, United States. It offers a fully automated,
next-generation sequencing Massive parallel sequencing or massively parallel sequencing is any of several high-throughput approaches to DNA sequencing using the concept of massively parallel processing; it is also called next-generation sequencing (NGS) or second-generation ...
(NGS) platform for turnkey diagnostics, including
SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) is a strain of coronavirus that causes COVID-19, the respiratory illness responsible for the COVID-19 pandemic. The virus previously had the Novel coronavirus, provisional nam ...
genomic characterization and detection of foodborne pathogens such as
listeria ''Listeria'' is a genus of bacteria that acts as an intracellular parasite in mammals. As of 2024, 28 species have been identified. The genus is named in honour of the British pioneer of sterile surgery Joseph Lister. ''Listeria'' species ...
and
salmonella ''Salmonella'' is a genus of bacillus (shape), rod-shaped, (bacillus) Gram-negative bacteria of the family Enterobacteriaceae. The two known species of ''Salmonella'' are ''Salmonella enterica'' and ''Salmonella bongori''. ''S. enterica'' ...
. It can also verify a food's ingredients, its GMO status, or conduct other tests. Clear Labs was co-founded by Sasan Amini and Mahni Ghorashi in 2014, who left their jobs at a genomics company to start Clear Labs. The company acquired $6.5 million in
series A A series A is the name typically given to a company's first significant round of venture capital financing. It can be followed by the word round, investment or financing. The name refers to the class of preferred stock sold to investors in exchan ...
financing in September 2015. In December 2016, the company closed a $16 million Series B funding round. This was followed by another $21 million round in October 2018. Clear Labs was granted an Emergency Use Authorization (EUA) from the US FDA in September 2020 for its SARS-CoV-2 descriptive diagnostic test. Clear Labs launched in January 2021 a groundbreaking solution for whole genome sequencing surveillance of SARS-CoV-2 and its mutations. Clear Labs announced in March 2021 that the company had reached a critical milestone of over 50% public health laboratory penetration with its
whole genome sequencing Whole genome sequencing (WGS), also known as full genome sequencing or just genome sequencing, is the process of determining the entirety of the DNA sequence of an organism's genome at a single time. This entails sequencing all of an organism's ...
SARS-CoV-2 product, including laboratories such as Nebraska, Nevada, New York, California and Kansas, among others. Clear Labs Raised a $60M Series C round led by Morgan Stanley and T. Rowe Price in May 2021. Clear Labs has also received governmental and professional certification for its food safety next generation sequencing platform, including from the International AOAC in December 2019 and the National Poultry Improvement Plan in October 2021.


Notes


References

{{reflist


External links


Official Website
Biotechnology companies of the United States Companies based in Menlo Park, California DNA sequencing